Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Enbrel improves plaque psoriasis symptoms in phase III study

June 27, 2003

VIC-acne completes phase I safety study

June 25, 2003

Shiseido synthesizes new MMP inhibitors

June 23, 2003

Dompe patents novel inhibitors of IL-8 and GROalpha-induced chemotaxis

June 18, 2003

Interim results for rAAT in otitis media

June 17, 2003

Fibrostat phase IIb trial cleared to commence

June 16, 2003

Nonhypercalcemic vitamin D analogues newly synthesized at Schering AG

June 16, 2003

Reepithelialization of second degree burns enhanced in pigs administered CNI-1493

June 16, 2003

Novel glucocorticoid agonists in early development at GSK

June 13, 2003

Life Medical Sciences cleared to begin pivotal trial of Repel-CV

June 12, 2003

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....